In the News: McMaster experts weigh in on Omicron variant

Omicron, a new COVID-19 variant of concern, has seen several countries including Canada instate a travel ban on some southern African countries.

November 30, 2021

Two headshot photos side-by-side. On the left is Dawn Bowdish. She is wearing a black shirt and fuschia blazer. On the right is Zain Chagla. He is wearing a grey button-up dress shirt.
Dawn Bowdish and Zain Chagla are professors in the Department of Medicine at McMaster. (Photos by JD Howell and Georgia Kirkos/McMaster University).

Experts Featured In This Story

Dawn Bowdish
Dawn Bowdish

Professor

See Profile
Zain Chagla
Zain Chagla

Associate Professor

See Profile

McMaster experts are weighing in as questions and concerns are raised over Omicron, a new COVID-19 variant of concern identified by the World Health Organization, which has been found in Canada.

The variant seems to be the “worst of all worlds,” immunologist and associate professor at McMaster Dawn Bowdish told CBC Radio, noting early data suggests it could be highly transmissible.

“It does look as though some antibodies induced by the vaccine will be less effective and perhaps ineffective, however, it’s early days,” she said.

“We need to get the virus in scientists’ hands to test to see if these doom and gloom predictions actually pan out.”

The new variant prompted many countries, including Canada, to instate travel bans on seven countries in southern Africa.

The “blind closures” don’t make scientific sense, said Zain Chagla, associate professor of medicine at McMaster, in an interview with The Canadian Press.

While the variant may have been discovered last week, it has likely been circulating for some time, he said, noting it may have been first detected in South Africa due to good genomic surveillance infrastructure.

“It doesn’t really make sense that we use rigid travel bans as a way of preventing cases, as compared to mitigating spread,” said Chagla.

He said this new variant should serve as a reminder of the importance of global vaccine equity.

“If we’re going to repeat the same mistakes this time and keep re-vaccinating our lowest risk populations and forget about our global duties, I’m pretty sure we’re going to see this scenario playing itself out over and over and over again.”

Three smiling researchers stand together in a lab.

McMaster researchers use friendly viruses to tackle inflammatory bowel disease

Researchers from Health Sciences and Engineering worked together on a targeted approach using bacteriophages to disarm harmful microbes without disrupting the broader gut ecosystem.
A racially diverse group of people sitting in a sunlit room.

Analysis: The ethics of being left out of health research

Research ethics boards must not become so preoccupied with the potential harm of participation that they overlook the certain harm of exclusion, write Sonia Anand, Gina Ogilvie and Vanessa Watts.
gloved hands reach into a sterile lab environment to work with chemicals.

McMaster and U of T announce early-stage life sciences venture fund with Genesys Capital 

The support for startups in Ontario promises to address health-care challenges, boost the Canadian economy and improve patient care.